Subbaya Subramanian

14PUBLICATIONS
22CO-AUTHORS
Cancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 29, 2026
The gut microbiome and colorectal cancer.

|May 19, 2025
A Novel Conditionally Replicative Oncolytic Adenovirus under the Control of the SALL4 Promoter Inhibits the Growth of Rhabdoid Tumors.

Satoru Oya, Hideki Yoshida, Akimasa Tomida

|Jan 22, 2024
Centrosomal Protein 55 (CEP55) Drives Immune Exclusion and Resistance to Immune Checkpoint Inhibitors in Colorectal Cancer.

Dechen Wangmo, Travis J Gates, Xianda Zhao

|Aug 26, 2023
Advancing Cancer Immunotherapy: From Molecular Mechanisms to Clinical Applications.

Xianda Zhao, Timothy Starr, Subbaya Subramanian

|May 16, 2023
Fecal Microbiota Restoration Modulates the Microbiome in Inflammation-Driven Colorectal Cancer.

Travis J Gates, Ce Yuan, Mihir Shetty

|Nov 27, 2021
Cancer Immunology and Immunotherapies: Mechanisms That Affect Antitumor Immune Response and Treatment Resistance.

Xianda Zhao, Subbaya Subramanian

Pageof 3

Frequent Collaborators

5 joint publications

Xianda Zhao

2 joint publications

Andrew C Nelson

2 joint publications

Timothy Starr

2 joint publications

Christopher Staley